Journal article
Irbesartan reduced progression of nephropathy caused by type 2 diabetes independent of the effect on blood pressure.
Authors
Rabbat CG
Journal
Annals of Internal Medicine, Vol. 136, No. 3, pp. 82–84
Publisher
American College of Physicians
Publication Date
May 1, 2002
DOI
10.7326/acpjc-2002-136-3-083
ISSN
1056-8751
